04.08.2021 23:55

Chemours Announces Pricing of Private Offering of $650 Million Aggregate Principal Amount of 4.625% Senior Unsecured Notes Due 2029


WILMINGTON, Del., Aug. 4, 2021 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced the pricing of the previously announced private offering of $650 million in aggregate principal amount of 4.625% senior unsecured notes due 2029 that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The offering is expected to close on or about August 18, 2021, subject to customary closing conditions. The notes will be Chemours' senior unsecured obligations and will be guaranteed by certain of its subsidiaries.

The net proceeds of the offering are expected to be used, together with cash on hand, (i) to fund the purchase price and accrued and unpaid interest for any and all of Chemours' outstanding 7.000% senior notes due 2025 (the "existing 2025 notes") validly tendered and accepted for payment pursuant to Chemours' previously announced cash tender offer for any and all of the existing 2025 notes (the "Tender Offer") and (ii) to the extent applicable, to fund the redemption price and accrued and unpaid interest for any existing 2025 notes that remain outstanding after the completion or termination of the Tender Offer.

The notes and the related guarantees have not been, and will not be, registered under the Securities Act or any state securities laws, and unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws. The notes are being offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and to non-U.S. persons in accordance with Regulation S under the Securities Act. 

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. This press release is not an offer to purchase or the solicitation of an offer to sell any of the existing 2025 notes. The Tender Offer referenced herein is being made only by and pursuant to the terms of the applicable Offer to Purchase and Consent Solicitation Statement. The statements in this press release with respect to the redemption of the existing 2025 notes do not constitute a notice of redemption under the indenture governing the existing 2025 notes. Any such notice has or will be sent to holders of existing 2025 notes only in accordance with the provisions of such indenture.

About The Chemours Company
The Chemours Company (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations.  Chemours delivers customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, mining, and oil and gas. Our flagship products include prominent brands such as Ti-Pure™, Opteon™, Freon™, Teflon™, Viton™, Nafion™, and Krytox™. In 2019, Chemours was named to Newsweek's list of America's Most Responsible Companies. Chemours has approximately 6,500 employees and 30 manufacturing sites serving approximately 3,300 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.

For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours or LinkedIn

Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans, prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. In addition, the current COVID-19 pandemic has significantly impacted the national and global economy and commodity and financial markets, which has had and we expect will continue to have a negative impact on our financial results. The full extent and impact of the pandemic is unknown and to date has included extreme volatility in the financial and commodity markets, a significant slowdown in economic activity, and increased predictions of a global recession. The public and private sector response has led to significant restrictions on travel, temporary business closures, quarantines, stock market volatility, and a general reduction in consumer and commercial activity globally. Matters outside our control have affected our business and operations and may continue to limit travel of employees to our business units domestically and internationally, adversely affect the health and welfare of our personnel, significantly reduce the demand for our products, hinder our ability to provide goods and services to customers, cause disruptions in our supply chains, adversely affect our business partners or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include, but are not limited to: the terms and timing of the offering, the Tender Offer and any redemptions of the existing 2025 notes; and the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2021 and June 30, 2021 and our Annual Report on Form 10-K for the year ended December 31, 2020. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

The Chemours Company (Chemours) is a global leader in titanium technologies, fluoroproducts and chemical solutions. (PRNewsfoto/The Chemours Company)


Jonathan Lock
VP, Corporate Development and Investor Relations

Cassie Olszewski
Media Relations and Financial Communications Manager

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/chemours-announces-pricing-of-private-offering-of-650-million-aggregate-principal-amount-of-4-625-senior-unsecured-notes-due-2029--301348802.html

SOURCE The Chemours Company

Nachrichten zu The Chemours Co When Issued

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu The Chemours Co When Issued

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
29.03.2018The Chemours OutperformBMO Capital Markets
07.08.2017The Chemours NeutralUBS AG
09.05.2016The Chemours OverweightBarclays Capital
18.09.2015The Chemours HoldArgus Research Company
18.08.2015The Chemours SellUBS AG
29.03.2018The Chemours OutperformBMO Capital Markets
09.05.2016The Chemours OverweightBarclays Capital
07.08.2017The Chemours NeutralUBS AG
18.09.2015The Chemours HoldArgus Research Company
18.08.2015The Chemours SellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für The Chemours Co When Issued nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen

Jetzt noch kostenlos anmelden!

Die Europäische Zentralbank will an ihrer lockeren Geldpolitik festhalten, obwohl in vielen Ländern Europas die Inflation anzieht. Doch wie lange kann sie diesen Kurs beibehalten? Chefvolkswirt Dr. Jörg Krämer wirft im Online-Seminar heute ab 18 Uhr einen Blick auf die Finanzmärkte.
Jetzt noch schnell reinklicken!

Meistgelesene The Chemours News

Keine Nachrichten gefunden.
Weitere The Chemours News
Börse Stuttgart Anlegerclub

The Chemours Peer Group News

Keine Nachrichten gefunden.

Heute im Fokus

DAX legt zu -- Vivendi-Tochter Universal Music mit starkem Börsengang -- Umwelthilfe verklagt BMW und Mercedes -- Aurora Cannabis verschiebt Bilanzvorlage -- Shell, Bechtle, Lufthansa im Fokus

Apple will wohl iPhones zur Erkennung von Depressionen einsetzen. GEA vor Verkauf des Kälteanlagengeschäfts in Frankreich. AstraZeneca investiert in Produktionsanlage in Dublin. Siemens Energy an Auftrag für Greenlink-Seekabel beteiligt. Cosco steigt als Partner bei HHLA-Terminal Tollerort ein. Vonovia rüstet 30.000 Dächer mit Photovoltaik-Anlagen aus.

Die 5 beliebtesten Top-Rankings

Diese Jobs werden künftig Roboter übernehmen
Billiger als der Mensch.
Bei diesen Unternehmen gibt es in Deutschland das höchste Gehalt
Bei diesen Unternehmen gibt es in Deutschland das höchste Gehalt
Rohstoffe: Die Gewinner und Verlierer im August 2021
Welcher Rohstoff macht das Rennen?
Die 30 weltgrößten Unternehmen
Es gibt hunderte milliardenschwere Unternehmen. Die Top 30.
Jobs mit Zukunft und hohem Gehalt
Hier wird man auch künftig noch gut bezahlt
mehr Top Rankings


Würden Sie es für richtig halten, wenn Gastronomie und Veranstaltungen nur noch Geimpften und Genesenen offen stehen?

finanzen.net zero
finanzen.net zero



Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln